Halma, the global group of life-saving technology companies, today announces that it has acquired Lamidey Noury Medical, a leading manufacturer of high-quality medical devices to assist surgeons operate more safely and efficiently.
Lamidey Noury, headquartered in Paris, France, is renowned for its excellence in designing and producing electrosurgical instruments. These instruments, widely adopted by healthcare professionals worldwide, are used for cutting tissue and controlling bleeding during operations, thereby improving patient outcomes and operational efficiencies.
The ageing population and rising incidence of urological and gynaecological diseases in younger patients are driving the demand for specialised medical care. Additionally, global healthcare spending is increasing, reflecting a prioritisation of health and well-being. The adoption of minimally invasive procedures, which offer shorter recovery times and lower risks, is also on the rise, making electrosurgical instruments essential for precise and controlled surgical interventions.
Electrosurgical instruments are part of a broader category of devices that enhance the efficiency and safety of procedures. They are essential in minimally invasive procedures because they allow for more precise and controlled interventions, reducing the risk of complications and improving patient outcomes.
Guillaume Noury, President of Lamidey Noury, said: “Joining Halma is an exciting opportunity for us. Leveraging Halma’s expertise, resources, and global reach will accelerate our growth and innovation. We are confident in our ability to continue delivering high-quality surgical tools to our customers worldwide, while providing new opportunities for our employees and stakeholders. Together, we will continue improving patient outcomes and driving excellence in healthcare.”
Marc Ronchetti, Group Chief Executive of Halma, said: “I am excited to welcome Lamidey Noury to Halma. This acquisition aligns perfectly with our mission of improving patient outcomes. Lamidey Noury’s innovative solutions will enhance our portfolio of minimally invasive surgical product capabilities. With Halma’s global reach and resources, we look forward to supporting its development as it continues to scale its business globally.”
Lamidey Noury will be a standalone company within Halma’s Healthcare sector, led by its current management team. This acquisition underscores Halma’s commitment to advancing healthcare through innovative solutions and strategic growth.
